Acta Pharmaceutica Sinica B
|
2026, 16(6): 3920-3933
• Original articles •
Development of bacterial sonosensitizer hybrid systems to enhance cancer sono-immunotherapy
Full
Haiyan Guo1, Yuhan Li1, Xue Chen1, Xiuru Ji1, Zeyang Liu1, Hongjing Jiang1, Han Wang1, Dalong Ni1
Affiliations
1 Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
doi: 10.1016/j.apsb.2026.03.024
Outline
Microorganisms can activate anti-tumor immune responses via the innate immune system. However, this immune effect lacks specificity, and prolonged stimulation by live bacterial colonization may lead to immune tolerance. Sonodynamic therapy triggers cellular death and lysis, fully activating the antigen presentation process by providing heterologous DNA and tumor antigen in situ. Herein, to enhance the immunological effect facilitated by ultrasonic treatment, a manganese-containing porphyrin-based metal-organic framework (Mn-MOF) was modified as an acoustic sensitizer on the surface of Escherichia coli to form bacterial sonosensitizer hybrid systems (HA@Mn-MOF@E). Importantly, HA@Mn-MOF@E was able to target and colonize 4T1 tumors due to the anoxic tendency of anaerobes. The ultrasound-induced bacterial and tumor cell death and released manganese could activate macrophages and dendritic cells (DCs) through the activation of the cGAS-STING pathway, which increased the proportion of CD3⁺ T cells and M1/M2 ratio within the tumor, as well as CD8⁺ effector T cells and CD86⁺ DCs in lymph nodes. By sono-sensitized immunotherapy, HA@Mn-MOF@E was demonstrated to inhibit orthotopic 4T1 tumor progression and induce tumor necrosis effectively. Such a designed bacterial sonosensitizer hybrid system offered the possibility of using sonodynamic assistance to sensitize live microorganisms-induced immunotherapy, with thorough activation of the antigen presentation in the tumor.
Bacteria
/
Sonosensitizer
/
Bacterial sonosensitizer hybrid systems
/
Live delivery system
/
Sono-immunotherapy
/
cGAS-STING pathway
/
Antigen-presentation
/
Breast cancer
Haiyan Guo, Yuhan Li, Xue Chen, Xiuru Ji, Zeyang Liu, Hongjing Jiang, Han Wang, Dalong Ni.
Development of bacterial sonosensitizer hybrid systems to enhance cancer sono-immunotherapy[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(6)
: 3920
-3933
.
DOI: 10.1016/j.apsb.2026.03.024
Year 2026 volume 16 Issue 6
PDF
6
3
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2026.03.024
- Receive Date:2025-06-25
- Online Date:2026-09-17